Delivery Order SPE2DB22D3019-SPE2DB25FK3HP

Award Date 3/21/25
Potential Completion Date 3/24/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,931.32, is for the delivery of 4566949237 - DEXTROAMP-AMPHET ER 10 MG CAP 100S, a pharmaceutical product. It is a Firm Fixed Price Delivery Order contract that runs through January 16, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $1,191.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB22D1202|SPE2DB25FUYU0) for the supply of 4568040534 - DEXTROAMP-AMPHET ER 10 MG CAP 100S, a pharmaceutical product. The contract has an ultimate completion date of April 28, 2025 and is a firm fixed-price arrangement. This contract is not associated with a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,994.27 firm-fixed-price delivery order is for DEXTROAMP-AMPHET ER 20 MG CAP 100S, with an ultimate completion date of January 14, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,226.92 firm fixed-price delivery order contract is for the supply of 4559234122 DEXTROAMP-AMPHET ER 20 MG CAP 100S, with a completion date of November 30, 2022. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,470.35, is a delivery order for the supply of 4566478383 ! DEXTROAMP-AMPHET ER 25 MG CAP 100S, a pharmaceutical product. The contract has an ultimate completion date of November 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of 4566544700 - DEXTROAMP-AMPHET ER 10 MG CAP 100S. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has a ceiling value of $2,088.63. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award, valued at $1,914.57, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566903471 - DEXTROAMP-AMPHETAMIN 20 MG TAB 100S, with a completion date of January 13, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,525.57 Firm Fixed Price delivery order is for the provision of 4563018142 - DEXTROAMP-AMPHETAMIN 10 MG TAB 100S. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,254.04, is a Firm Fixed Price Delivery Order for the supply of 4565778853 DEXTROAMP-AMPHET ER 25 MG CAP 100S. The contract has a completion date of September 12, 2024 and was awarded on September 11, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $1,347.01 and is a Firm Fixed Price Delivery Order that runs through February 26, 2025. The contract is for the supply of DEXTROAMP-AMPHETAMIN 10 MG TAB 100S, a pharmaceutical product, to support federal healthcare programs. Amerisourcebergen holds a larger Indefinite Delivery Contract...
  • SPE2DB22D3019
    Indefinite Delivery Contract
  • SPE2DB22D3019-SPE2DB25FK3HP
    Delivery Order

This federal contract award, valued at $1,394.24, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567702249 DEXTROAMP-AMPHET ER 20 MG CAP 100S, a pharmaceutical product, and does not have a set-aside designation.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. In addition, the company maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 6/21/25, 9:42 AM